These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 2496716
1. Reduction of p24 antigen levels in asymptomatic patients using twice-daily zidovudine. Gill S, Thin N, Cordery M, Spacey B, Barlow D. AIDS; 1989 Jan; 3(1):48-9. PubMed ID: 2496716 [No Abstract] [Full Text] [Related]
2. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Spector SA, Kennedy C, McCutchan JA, Bozzette SA, Straube RG, Connor JD, Richman DD. J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173 [Abstract] [Full Text] [Related]
3. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P. Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098 [Abstract] [Full Text] [Related]
4. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS. Reddy MM, McKinley G, Englard A, Grieco MH. J Clin Lab Anal; 1989 Oct; 3(4):199-201. PubMed ID: 2503599 [Abstract] [Full Text] [Related]
5. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS. Borghi V, De Rienzo B, Pietrosemoli P, Pecorari M, Mongiardo N, Pellegrino F, Zanchetta GP, Lami G, Squadrini F. Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304 [Abstract] [Full Text] [Related]
6. Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients. Lange JM, de Wolf F, Mulder JW, Coutinho RA, van der Noordaa J, Goudsmit J. J Infect; 1989 Jan; 18 Suppl 1():85-91. PubMed ID: 2492586 [Abstract] [Full Text] [Related]
9. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex. Pinching AJ, Helbert M, Peddle B, Robinson D, Janes K, Gor D, Jeffries DJ, Stoneham C, Mitchell D, Kocsis AE. J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663 [Abstract] [Full Text] [Related]
10. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients]. Tamalet C, Puel J, Fleury H, Ferchal F, Agut H, Brun-Vezinet F, Botti G, Rouzioux C. Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642 [Abstract] [Full Text] [Related]
11. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study. Merigan TC, Skowron G, Bozzette SA, Richman D, Uttamchandani R, Fischl M, Schooley R, Hirsch M, Soo W, Pettinelli C. Ann Intern Med; 1989 Feb 01; 110(3):189-94. PubMed ID: 2536257 [Abstract] [Full Text] [Related]
12. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A. J Infect Dis; 1989 Jun 01; 159(6):1029-36. PubMed ID: 2566637 [Abstract] [Full Text] [Related]
18. [Elevation of HIV-antigen concentration during administration of zidovudine]. Valencia ME, Gil A, Pintado V, Zapico RM. Med Clin (Barc); 1993 Feb 13; 100(6):239. PubMed ID: 8429735 [No Abstract] [Full Text] [Related]
20. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS]. de Gans J, Lange JM, Derix MM, de Wolf F, Ongerboer de Visser BW, Goudsmit J. Ned Tijdschr Geneeskd; 1988 Sep 03; 132(36):1656-60. PubMed ID: 3050555 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]